Innoviz Technologies (NASDAQ:INVZ) Given "Sell (D-)" Rating at Weiss Ratings

Key Points

• Weiss Ratings has reissued a "sell (D-)" rating for Innoviz Technologies (NASDAQ:INVZ), indicating caution for investors based on recent analysis.
• Despite the sell rating from Weiss, Westpark Capital and Goldman Sachs have provided buy ratings with price targets of $3.30 and $2.50 respectively, suggesting mixed analyst sentiment surrounding the stock.
• Innoviz Technologies reported a loss of $0.09 per share for the last quarter, slightly below analysts' expectations, and is projected to post negative earnings for the current year.

Innoviz Technologies (NASDAQ:INVZ - Get Free Report)'s stock had its "sell (d-)" rating reissued by equities research analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Other equities research analysts have also recently issued reports about the company. Westpark Capital lifted their price objective on Innoviz Technologies from $2.53 to $3.30 and gave the stock a "buy" rating in a report on Thursday, August 14th. The Goldman Sachs Group set a $2.50 target price on Innoviz Technologies and gave the company a "buy" rating in a research report on Monday, September 29th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $3.27.

Innoviz Technologies Price Performance

Shares of NASDAQ:INVZ opened at $2.24 on Wednesday. Innoviz Technologies has a 1 year low of $0.45 and a 1 year high of $3.14. The firm has a market capitalization of $450.96 million, a price-to-earnings ratio of -5.33 and a beta of 1.30. The business's 50 day moving average price is $1.78 and its 200-day moving average price is $1.29.

Innoviz Technologies (NASDAQ:INVZ - Get Free Report) last posted its quarterly earnings data on Wednesday, August 13th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.01). The company had revenue of $9.75 million for the quarter, compared to analyst estimates of $9.00 million. Innoviz Technologies had a negative return on equity of 80.09% and a negative net margin of 197.89%. Innoviz Technologies has set its FY 2025 guidance at EPS. On average, sell-side analysts expect that Innoviz Technologies will post -0.6 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Bank Hapoalim BM acquired a new position in Innoviz Technologies during the second quarter worth $26,000. O ROURKE & COMPANY Inc purchased a new stake in shares of Innoviz Technologies in the 2nd quarter valued at $33,000. WMG Financial Advisors LLC purchased a new stake in shares of Innoviz Technologies in the 2nd quarter valued at $34,000. Corsair Capital Management L.P. acquired a new position in Innoviz Technologies in the 2nd quarter valued at about $41,000. Finally, Quadrature Capital Ltd acquired a new position in Innoviz Technologies in the 2nd quarter valued at about $44,000. 63.26% of the stock is currently owned by institutional investors and hedge funds.

Innoviz Technologies Company Profile

Innoviz Technologies Ltd. manufactures and sells automotive grade LiDAR sensors and perception software to enable safe autonomous driving at a mass scale. The company offers InnovizOne, a solid-state LiDAR sensor designed for automakers and robotaxis, shuttles, trucks, and delivery companies requiring an automotive-grade and mass-producible solution to achieve autonomy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.